U.S. Global Investors, Inc. (GROW) is a San Antonio-based boutique registered investment adviser founded in 1968. It manages actively managed mutual funds and thematic exchange-traded funds focused on gold and precious metals, natural resources, airlines, and luxury goods, alongside a government ultra-short bond fund. Because of its small size and thin trading, traditional sell-side firms provide almost no formal price targets.
MarketBeat reports no consensus price target for the stock, and TipRanks lists a single reiterated target of $2.50 from February 2026, below the current price. Weiss Ratings, a model-driven ratings provider rather than a conventional sell-side analyst, downgraded the name to Hold in September 2026. With no reliable multi-analyst consensus to calculate, the $3.00 objective used here comes from public technical and valuation discussion rather than an analyst aggregate. It represents a round-number psychological level that coincides with the roughly $2.89 to $3.23 zone cited in recent technical commentary and a widely referenced $3.00 invalidation level.
With shares recently changing hands near $2.60, a move to $3.00 would require an advance of approximately 15% — a substantial move for a micro-cap that trades modest daily volume. The stock's 52-week range spans about $2.23 to $3.65, so $3.00 is well below the prior high and does not require a new record. The company ended its most recent reported quarter with average assets under management (AUM) of roughly $1.6 billion, operating revenue of about $2.8 million, and net income near $2.7 million. Its market capitalization is only about $31 million to $33 million, while its balance sheet carries essentially no debt and a cash position in the low-to-mid $20 million range.
Several balance-sheet and capital-allocation features stand out. The company has no long-term debt and holds substantial cash relative to its market value, which cushions operations and funds its shareholder-return program. It pays a recurring monthly dividend (yielding roughly 3.5%) and has reduced its share count by about 15% over five years through buybacks, supporting per-share metrics. Demand for its gold, precious-metals, and natural-resources funds could lift AUM and management fees if commodity and inflation themes regain momentum, directly improving revenue and earnings.
The clearest headwinds are structural. Revenue has declined markedly from prior years as fee-based income follows volatile AUM, and operating and free cash flow have been thin or negative in recent periods. The stock's limited liquidity — average volume in the low tens of thousands of shares — makes price moves erratic and widens bid-ask spreads. A meaningful decline in commodity sentiment, continued fee compression, or a loss of fund assets would weigh on results. With essentially no sell-side support, the shares also lack the institutional sponsorship that can anchor valuations.
Published technical analysis identifies near-term support around $2.58, with additional support near $2.52 and $2.29 and the 52-week low near $2.23. On the upside, short-term resistance sits near $2.82, followed by mid-term and longer-term resistance in the $3.33 to $3.36 zone, just under the 52-week high of $3.65. The 200-day moving average has hovered near $2.65 to $2.72. The $3.00 objective therefore lies between the first resistance band and the more durable resistance zone in the low-$3.30s.
Because the $3.00 figure is a technical and valuation objective rather than a formal analyst target, it carries no defined research horizon. Investors should watch quarterly AUM and revenue trends, dividend declarations, share-buyback activity, and any filings or announcements affecting fund flows. Broader drivers such as gold and commodity prices, interest-rate expectations, and sector rotation into or out of precious-metals and natural-resources funds are also directly relevant to fee income and sentiment.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. For a thin, low-liquidity name like GROW, such tools can help traders spot changing trends and shifts in technical structure more efficiently than manual chart review. Traders use these signals to discover opportunities, monitor existing positions, and react to emerging patterns. Explore the signals to see how AI-driven monitoring can complement your own research process.
Whether U.S. Global Investors (GROW) can reach $3.00 is an open question. The target is not an analyst consensus — there is effectively none — but a publicly discussed technical and psychological level roughly 15% above the recent price. The strongest supports are a clean balance sheet, ample cash, a monthly dividend, and buybacks, while the biggest obstacles are declining revenue, thin cash flow, poor liquidity, and absent institutional coverage. A sustained rise in AUM and commodity-related fund demand would be the most direct path higher; persistent fee erosion or outflows would argue against it. Investors should monitor AUM, dividend and buyback activity, and precious-metals sentiment rather than expect a defined analyst roadmap.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that GROW and NEWT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GROW and NEWT's prices will move in lockstep.
| Ticker / NAME | Correlation To GROW | 1D Price Change % | ||
|---|---|---|---|---|
| GROW | 100% | -1.54% | ||
| NEWT - GROW | 31% Poorly correlated | -1.18% | ||
| IVZ - GROW | 30% Poorly correlated | -0.14% | ||
| DBRG - GROW | 29% Poorly correlated | N/A | ||
| BUR - GROW | 28% Poorly correlated | -1.62% | ||
| PAX - GROW | 26% Poorly correlated | -2.12% | ||
More | ||||